Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

A Star-Laden Biotech SPAC Worth Considering

TheMotleyFool

0 0

A Star-Laden Biotech SPAC Worth Considering

In this video from Motley Fool Live, recorded on March 22, Fool.com contributors Brian Orelli and Keith Speights discuss the prospects for Revolution Health Acquisition Corp. (NASDAQ: REVH.U). The healthcare-focused special purpose acquisition company (SPAC) is sponsored by ARCH Ventures and General Catalyst and has some solid leadership at the helm, including former CEO of Vertex (NASDAQ: VRTX) Jeffrey Leiden who serves as the SPAC's chairman.